Dr. Cromie serves as the European Director of Clinical Pharmacology Sciences within one of the largest and most experienced global groups of its kind in industry. Based in the UK, she is responsible for all European Sponsor deliverables in the areas of modeling and simulation, study design and protocol development, biostatistics, pharmacokinetics, and medical writing. Dr. Cromie is also responsible for ensuring European standards and regulatory requirements are an integral part of the harmonised global processes within Celerion’s global Clinical Pharmacology Sciences group. In her role, Dr. Cromie provides European Sponsors with the opportunity of taking advantage of Celerion’s large global clinical presence while working consistently with a European Clinical Pharmacology Sciences team across drug development programs.
Dr. Cromie has over 15 years experience in early clinical research, providing her with an in-depth understanding of the clinical pharmacology challenges faced by clients. She has extensive experience in study design, with publications and presentations in the areas of study design, safety, PK and efficacy of new compounds. Her current focus is on innovative and adaptive study designs to increase clinical trial efficiency and accelerate drug development decisions.
Dr. Cromie joined MDS Harris in 1996 and held positions of increasing responsibility within the Clinical Pharmacology Sciences department before taking on her current role in 2007. She has a BSc in Biology and a PhD in Zoology both from The Queen’s University of Belfast.